60 DEGREES PHARMACEUTICALS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2021 | — | $-18.2M | $115.4K |
| Mar 2022 | — | $-19.0M | — |
| Jun 2022 | — | $-21.0M | $751.5K |
| Sep 2022 | — | $-22.5M | $439.4K |
| Dec 2022 | $16.9M | $-23.6M | $264.9K |
| Mar 2023 | — | $-21.4M | $30.0K |
| Jun 2023 | $24.6M | $-22.3M | $19.1K |
| Sep 2023 | $150.0K | $6.5M | $2.2M |
| Dec 2023 | $150.0K | $4.9M | $2.1M |
| Mar 2024 | $150.0K | $7.2M | $2.9M |
| Jun 2024 | $150.0K | $3.0M | $1.6M |
| Sep 2024 | $150.0K | $6.0M | $3.3M |
| Dec 2024 | $147.1K | $4.0M | $1.7M |
| Mar 2025 | $150.0K | $4.1M | $3.5M |
| Jun 2025 | $150.0K | $2.4M | $2.0M |
| Sep 2025 | $150.0K | $4.4M | $4.1M |
| Dec 2025 | $144.0K | $3.5M | $1.5M |
| Mar 2026 | $150.0K | $4.8M | $3.3M |
| Jun 2026 | $150.0K | $2.6M | $1.0M |